Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.109999
Revised: August 1, 2025
Accepted: August 18, 2025
Published online: October 27, 2025
Processing time: 114 Days and 16.8 Hours
Primary liver cancer is a globally prevalent malignancy, with China accounting for approximately 55% of new cases, and is linked to hepatitis B, aflatoxin, and cirrhosis. Its rupture with hemorrhagic shock is a lethal complication with high mortality, and traditional triage struggles with timely risk stratification, necessi
To study and analyze the combined effect of the SI and EWS in primary liver cancer patients with ruptured hemorrhage and shock.
In total, 118 patients who visited the Emergency Department of Nantong Third People's Hospital from January 2023 to December 2024 were selected and ran
The emergency, triage, waiting, and hemostasis times, as well as hospital stay were shorter in the observation group than in the control group (P < 0.05). After 48 hours of emergency intervention, blood oxygen saturation and partial pressure of oxygen in the observation group were higher than those in the control group (P < 0.05). Seven days after emergency intervention, the hemoglobin, prealbumin, and albumin levels were higher in the observation group than in the control group (P < 0.05). The complication rate in the observation group was 3.39%, lower than that in the control group (13.56%; P < 0.05). Satisfaction with emergency intervention in the observation group was 94.92%, higher than 83.05% in the control group (P < 0.05).
The combined application of the SI and EWS in patients with primary liver cancer rupture, hemorrhage, and shock can significantly shorten emergency treatment time, improve respiratory function and serological indicators, reduce the incidence of complications, and enhance patient satisfaction with emergency interventions, with higher clinical treatment efficiency and quality. Therefore, it is worthy of promotion and application.
Core Tip: This study demonstrated that combining the shock index (SI, heart rate/systolic blood pressure ratio) with the early warning score (EWS) significantly improves outcomes in primary liver cancer rupture hemorrhage. The SI-EWS protocol reduced emergency response time by 32% and complication rates by 75% (3.39% vs 13.56%), and increased patient satisfaction to 94.92%. This integrated approach enhances hemodynamic monitoring accuracy, enabling faster hemorrhage control and better preservation of respiratory function and nutritional status (hemoglobin/prealbumin levels). These findings support the use of SI-EWS as a standardized triage tool for high-risk abdominal hemorrhage cases.
- Citation: Ma JF, Jin L, Sha L, Li HF, Qian XY, Wang HY. Shock index and early warning score in liver cancer rupture shock. World J Gastrointest Surg 2025; 17(10): 109999
- URL: https://www.wjgnet.com/1948-9366/full/v17/i10/109999.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i10.109999
Primary liver cancer is the sixth most common malignant tumor globally, with the third highest mortality rate. New cases in China account for approximately 55% of the global total, mainly associated with hepatitis B virus infection, aflatoxin exposure, and a high incidence of liver cirrhosis[1,2]. As the disease progresses, rapid tumor growth in primary liver cancer can lead to local ischemic necrosis and erosion of intrahepatic blood vessels. The progression of cirrhosis and exacerbation of portal hypertension further increases vascular fragility, making even a slight increase in abdominal pressure a potential trigger for rupture and hemorrhage, which is one of the most critical clinical complications[3,4]. Notably, 8%-15% of patients with primary liver cancer experience tumor rupture and hemorrhage, which often pro
Traditional assessment methods for such critical conditions, which rely on single parameters such as blood pressure and heart rate (HR), have significant limitations owing to their lag in reflecting dynamic changes in patient status. In contrast, the shock index (SI) and early warning score (EWS) systems have emerged as more robust tools for risk stratification and timely intervention.
The SI, calculated as the ratio of HR (beats/min) to systolic blood pressure (SBP) (mmHg), is a simple yet effective hemodynamic parameter that dynamically reflects shock severity. It enables rapid identification of circulatory instability: An SI ≥ 1 indicates high risk, requiring immediate emergency protocols, while values between 0.5 and 1 suggest moderate risk, necessitating intensive monitoring[7,8]. This index integrates two key vital signs to overcome the limitations of isolated parameters and provides a more comprehensive assessment of perfusion status.
The EWS system, on the contrary, is a multi-parametric tool that evaluates HR, SBP, respiratory rate, body tempera
Both tools have demonstrated utility in acute care settings; SI enhances the accuracy of hemodynamic monitoring, whereas EWS captures multisystem instability. However, their combined application in primary liver cancer rupture with hemorrhagic shock remains underexplored. Given the high mortality and challenges in early triage for this condition, this study aimed to investigate the efficacy of integrating the SI and EWS system, with the goal of optimizing emergency intervention, improving patient outcomes, and providing a standardized triage approach for clinical practice.
In total, 118 patients who visited the Emergency Department of Nantong Third People's Hospital between January 2023 and December 2024 were selected. After obtaining informed consent from the patients' families, they were randomly divided into an observation group (n = 59) and a control group (n = 59) by drawing lots. Table 1 compares the baseline characteristics of the patients in the observation group (59 cases) and the control group (59 cases), including sex, age, tumor diameter, and distribution type. The results showed that there were no significant differences between the two groups in terms of sex (61.02% and 57.63% males, respectively), mean age (53.78 ± 6.21 years vs 53.42 ± 6.35 years), mean tumor diameter (6.52 ± 1.36 cm vs 6.45 ± 1.39 cm), and tumor distribution type (diffuse type 38.98% vs 37.29%, nodular type 52.54% vs 55.93%, mass type 8.47% vs 6.78%; χ2/t-values were 0.170, 0.311, 0.277, and 0.215, respectively, with all P values > 0.05), indicating that the baseline characteristics of the two groups were balanced and similar.
| Group | Observation (n = 59) | Control (n = 59) | χ2/t | P value |
| Sex | ||||
| Male | 36 (61.02) | 34 (57.63) | 0.170 | 0.680 |
| Female | 23 (38.98) | 25 (42.37) | ||
| Age (years) | 53.78 ± 6.21 | 53.42 ± 6.35 | 0.311 | 0.756 |
| Tumor diameter (cm) | 6.52 ± 1.36 | 6.45 ± 1.39 | 0.277 | 0.782 |
| Distribution pattern | ||||
| Diffuse type | 23 (38.98) | 22 (37.29) | 0.215 | 0.898 |
| Nodular type | 31 (52.54) | 33 (55.93) | ||
| Block type | 5 (8.47) | 4 (6.78) |
The inclusion criteria were as follows: (1) Diagnosis of primary liver cancer rupture hemorrhage and shock by imaging and pathological examinations in accordance with the Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)[9]; (2) Expected survival period of > 3 months; (3) Time from rupture hemorrhage and shock to admission of < 24 hours; (4) No other serious complications or comorbidities; and (5) No other specific treatment for liver cancer.
The exclusion criteria were: (1) Presence of other malignant tumors; (2) Severe dysfunction of the heart, lung, kidney, and other organs; (3) Allergic reactions to related therapeutic drugs; (4) Mental illness or cognitive impairment, inability to cooperate with the researcher; and (5) Withdrawal from the study or loss to follow-up midway. This study was approved by the hospital’s ethics committee. There were no significant differences in the baseline data between the two groups (P > 0.05) (Table 1).
Control group: Patients in the control group were given routine emergency treatment measures: (1) SBP < 90 mmHg and HR > 100 beats/min as evaluation parameters, and monitored and recorded every hour; (2) Rapidly establishing an intravenous channel, empirically infusing 0.9% normal saline at an initial speed of 15 mL/kg/30 minutes; (3) When hemoglobin (Hb) was < 7 g/dL, infusing concentrated red blood cells to supplement blood volume and maintain blood pressure stability; (4) Giving hemostatic drugs such as tranexamic acid, somatostatin, and thrombin to control bleeding; when blood pressure continued to be low, 5-10 μg/kg/min dopamine was used; (5) Using liver-protecting drugs such as polyene phosphatidylcholine and diammonium glycyrrhizinate to protect liver function; and (6) During the treatment, closely monitoring the patient's vital signs, including blood pressure, HR, respiration, and body temperature, as well as indicators such as liver and kidney functions and electrolytes, and adjusting the treatment plan in a timely manner according to the condition changes.
Observation group: On the basis of routine emergency treatment, the SI and EWS system were combined to assess the condition of patients in the observation group, and for intervention: (1) After admission, the patient's shock degree was immediately evaluated by the formula SI = pulse (beats/min)/SBP (mmHg), and it was monitored and calculated every 1 hour. Combined with other indicators such as lactate and urine output, the resuscitation effect was assessed, and hierarchical management was performed according to the obtained scores: For patients with SI ≥ 1, it indicated a high risk, and an emergency treatment process needed to be started. A multidisciplinary team of emergency, critical care medicine, interventional radiology, gastroenterology, hepatobiliary surgery, transfusion, and other physicians and nursing teams conducted emergency consultations to consider blood transfusion, vasoactive drugs, or emergency surgery, etc.; for those with SI between 0.5 and 1, it indicated a moderate risk, and intensive monitoring was required to optimize fluid resuscitation, maintain hemodynamic stability, and prepare necessary treatment measures; and for those with SI < 0.5, it indicated a low risk, indicating stable circulatory status, but continuous attention to condition changes was still required. The EWS system was used to comprehensively evaluate the patients’ HR, SBP, respiratory rate, body temperature, consciousness status, and other indicators. Evaluations were conducted every 2 hours during the acute phase and every 4 hours during the stable phase. If the total score was continuously < 5 points twice, it was adjusted to two times per day. The specific scoring criteria for "0 points" included: SBP 101-199 mmHg, HR 60-100 beats/min, respiratory rate 12-20 breaths/min, body temperature 35.0-38.4 ℃, and clear consciousness; "1 point" indicators included: SBP 81-100 mmHg, HR 51-60 beats/min or 101-120 beats/min, respiratory rate 9-11 breaths/min or 21-25 breaths/min, and consciousness responsive to sound; "2 points" indicators included: SBP 71-80 mmHg or 200-219 mmHg, HR 41-50 beats/min or 121-139 beats/min, respiratory rate 26-29 breaths/min or ≤ 8 breaths/min, body temperature < 35.0 ℃ or 38.5-39.9 ℃, and consciousness responsive to pain; "3 points" indicators included: SBP ≤ 70 mmHg or ≥ 220 mmHg, HR ≤ 40 beats/min or ≥ 140 beats/min, respiratory rate ≥ 30 breaths/min, and unconsciousness. According to the evaluation results, corresponding treatment measures were taken: When the total score was ≥ 5 points, it indicated that the patient's condition was critical, and immediate intensive monitoring and rapid intervention were required, such as increasing the speed of fluid resuscitation, adjusting the dose of vasoactive drugs, and preparing for mechanical ventilation; a total score of 3-4 points indicated that the patient's condition was severe, and close attention to the condition changes was required, strengthening fluid management, and preparing necessary treatment equipment; and a total score of ≤ 2 points indicated that the patient's condition was relatively stable, but regular evaluation was still required to prevent the condition from worsening. By combining the SI and EWS, the patients were divided into three levels: Green (SI < 1.0, EWS < 5), yellow (SI ≥ 1.0 or EWS ≥ 5), and red (SI > 1.5, EWS > 7), corresponding to low, moderate, and high risk, respectively. Corresponding treatment measures were taken at different levels: Green, routine monitoring to avoid excessive intervention; yellow, multidisciplinary team consultation to optimize fluid resuscitation and hemostasis strategies; and red, immediate transfer to the intensive care unit (ICU) to start advanced life support treatment measures such as mechanical ventilation and continuous renal replacement therapy.
The clinical treatment situation, specifically defined as the time intervals and durations reflecting the efficiency of emergency management; respiratory function indicators, which quantify the oxygenation and ventilation status of the respiratory system; serological indicators, which assess the body's nutritional status, hematopoietic function, and organ synthesis capacity; complications, including adverse events related to hemorrhage, infection, and organ dysfunction; and satisfaction with emergency intervention before and after the emergency intervention, were compared between the two groups.
This included emergency time (from patient arrival at the emergency department to initiation of targeted first aid measures such as venous access establishment or blood transfusion preparation), triage time (from initial patient assessment to determination of priority level for treatment), waiting time (from completion of triage to the start of specific hemostatic intervention), hemostasis time (from confirmation of bleeding site to clinical cessation of active hemostasis, as indicated by stable vital signs and no fresh bleeding in drainage fluid), and hospital stay (total duration from admission to discharge).
An ABL90 FLEX arterial blood gas analyzer (produced by Radiometer Medical ApS, Denmark) was used for detection. Blood oxygen saturation (SpO2, a key indicator of oxygenation status, normal range 95%-100%) and partial pressure of oxygen (PaO2, reflecting the oxygen pressure in arterial blood, normal range 80-100 mmHg) were recorded at admission and at 48 h after the emergency intervention to evaluate the improvement in respiratory function.
Fasting venous blood (5 mL) was collected from patients at admission and at 7 days after the emergency intervention. Hb, a core indicator of red blood cell oxygen-carrying capacity (normal range 120-160 g/L for males and 110-150 g/L for females), prealbumin (PAB, a sensitive marker of acute nutritional status, normal range 200-400 mg/L), and albumin (Alb, reflecting liver synthetic function and systemic nutritional status, normal range 35-50 g/L) were measured. Hb levels were measured using an automatic blood cell analyzer, whereas PAB and Alb levels were detected using an automatic biochemical analyzer. The kits were purchased from Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and the experiments were performed strictly in accordance with the manufacturer’s instructions.
Re-bleeding (recurrence of hemorrhage within 72 hours after initial hemostasis, confirmed by increased drainage volume or drop in Hb), abdominal effusion (excessive fluid accumulation in the abdominal cavity detected by ultrasonography, with a depth of > 3 cm), infection (body temperature ≥ 38.5 ℃ lasting > 24 hours, accompanied by positive blood or abdominal fluid culture), and multiple organ function injury (Sequential Organ Failure Assessment score ≥ 2 points in ≥ 2 organ systems) were observed. The number of complications in the two groups was counted, and complication rates were calculated.
The self-made emergency intervention satisfaction questionnaire of the hospital was used for evaluation, which included eight items covering emergency response speed, doctor-patient communication, treatment effectiveness, and nursing care quality, using a 4-point Likert scale (1 = very dissatisfied, 4 = very satisfied). The questionnaire was distributed to the patients or their families 1 day before discharge, and they completed the questionnaire according to their own feelings.
SPSS 22.0 was used for analysis. Enumeration data [n (%)] were tested using the χ2 test; measurement data (mean ± SD) conforming to normal distribution were tested using the t-test, and P < 0.05 was considered statistically significant.
The emergency, triage, waiting, and hemostasis times and hospital stay were shorter in the observation group than in the control group (P < 0.05) (Table 2).
| Group | Emergency time (minutes) | Time of triage (minutes) | Wait time (minutes) | Time to stop bleeding (hours) | Length of stay (days) |
| Observation (n = 59) | 29.58 ± 5.46 | 10.23 ± 2.06 | 4.56 ± 1.69 | 4.32 ± 1.50 | 8.77 ± 2.06 |
| Control (n = 59) | 35.72 ± 8.52 | 12.15 ± 2.84 | 5.28 ± 1.74 | 5.14 ± 1.63 | 10.23 ± 2.84 |
| t | 4.873 | 4.326 | 2.317 | 2.972 | 3.041 |
| P value | < 0.001 | < 0.001 | 0.022 | 0.004 | 0.003 |
There were no significant differences in SpO2 and PaO2 between the two groups at admission (P > 0.05). After 48 hours of emergency intervention, SpO2 and PaO2 in the observation group were higher than those in the control group (P < 0.05) (Table 3).
| Group | Degree of blood oxygen saturation; oxygen saturation of blood (%) | Partial pressure of oxygen (mmHg) | ||
| On admission | Emergency intervention was performed 7 days later | On admission | Emergency intervention 48 hours later | |
| Observation (n = 59) | 92.32 ± 0.48 | 98.74 ± 0.61 | 56.38 ± 1.49 | 95.70 ± 1.12 |
| Control (n = 59) | 92.43 ± 0.50 | 96.34 ± 0.87 | 56.57 ± 1.54 | 92.33 ± 1.46 |
| t | 1.243 | 15.249 | 0.715 | 13.742 |
| P value | 0.217 | < 0.001 | 0.476 | < 0.001 |
There were no significant differences in the levels of Hb, PAB, or Alb between the two groups at admission (P > 0.05). After 7 days of emergency intervention, the levels of Hb, PAB, and Alb were higher in the observation group than in the control group (P < 0.05) (Table 4).
| Group | Hb (g/L) | PAB (mg/L) | Alb (mg/L) | |||
| On admission | Emergency intervention was performed 7 days later | On admission | Emergency intervention was performed 7 days later | On admission | Emergency intervention was performed 7 days later | |
| Observation (n = 59) | 92.50 ± 5.26 | 105.76 ± 6.54 | 0.22 ± 0.04 | 0.43 ± 0.05 | 30.54 ± 2.13 | 34.55 ± 2.58 |
| Control (n = 59) | 92.84 ± 5.38 | 101.57 ± 6.02 | 0.23 ± 0.05 | 0.40 ± 0.04 | 30.65 ± 2.20 | 32.64 ± 2.49 |
| t | 0.360 | 3.646 | 1.204 | 3.651 | 0.281 | 4.140 |
| P value | 0.720 | < 0.001 | 0.231 | < 0.001 | 0.779 | < 0.001 |
Table 5 presents a comparison of the postoperative complications between the observation and control groups (n = 59 each). The overall complication rate was significantly lower in the observation group (3.39%) than in the control group (13.56%; χ2 = 6.061, P = 0.014). Specifically, the observation group reported one case each of pyoperitoneum (1.69%) and infection (1.69%), with no re-hemorrhage or multi-organ dysfunction. In contrast, the control group experienced higher incidences across all categories, including hemorrhage (3.39%), pyoperitoneum (5.08%), infection (3.39%), and multiorgan dysfunction (1.69%). These results suggest that combined interventions reduce the risk of postoperative complications.
| Group | Re-hemorrhagia | Pyoperitoneum | Infection | Multi-organ dysfunction | Complications (rate) |
| Observation (n = 59) | 0 (0.00) | 1 (1.69) | 1 (1.69) | 0 (0.00) | 2 (3.39) |
| Control (n = 59) | 2 (3.39) | 3 (5.08) | 2 (3.39) | 1 (1.69) | 8 (13.56) |
| χ2 | - | - | - | - | 6.061 |
| P value | - | - | - | - | 0.014 |
Table 6 summarizes patient satisfaction with emergency interventions in both groups. The observation group showed a significantly higher overall satisfaction rate (94.92%) than the control group (83.05%) (χ2 = 5.943, P = 0.015). In the observation group, 54.24% of the patients were very satisfied and 40.68% were fairly satisfied, with only 5.08% expressing dissatisfaction. Conversely, the control group had lower rates of very satisfied responses (37.29%) and higher rates of dissatisfaction (16.95%). These findings indicate that a combined diagnostic and treatment approach may enhance patient satisfaction in emergency settings.
| Group | Very satisfied | Fairly satisfied | Dissatisfied | Satisfaction (rate) |
| Observation (n = 59) | 32 (54.24) | 24 (40.68) | 3 (5.08) | 56 (94.92) |
| Control (n = 59) | 22 (37.29) | 27 (45.76) | 10 (16.95) | 49 (83.05) |
| χ2 | - | - | - | 5.943 |
| P value | - | - | - | 0.015 |
Rupture, hemorrhage, and shock are common serious complications of primary liver cancer. This condition is extremely dangerous and progresses rapidly. A large amount of blood quickly flows into the abdominal cavity, leading to a sudden drop in the effective circulatory blood volume and insufficient perfusion of important organs such as the brain, kidneys, and liver. This can cause irreversible damage and eventually lead to multiple organ failure with a high mortality rate. Studies have shown that the 24-hour mortality rate exceeds 70% in patients who do not receive emergency hemostasis treatment in time[10]. Moreover, the pathological mechanisms of primary liver cancer rupture, hemorrhage, and shock are complex and involve multiple aspects such as liver tumor rupture, damage to surrounding blood vessels, and abnormal coagulation function, which can lead to serious complications such as rebleeding, abdominal infection, sepsis, and acute liver failure[11,12], further increasing the difficulty and complexity of clinical treatment. Therefore, a timely and accurate evaluation of the patient's condition and effective emergency intervention measures are of great significance for improving the treatment success rate and reducing the incidence of complications and mortality in patients with primary liver cancer rupture, hemorrhage, and shock.
The results showed that the emergency, triage, waiting, and hemostasis times and hospital stay were shorter in the observation group than in the control group (P < 0.05). We believe that traditional clinical practice relies on isolated parameters such as blood pressure and HR, and that the monitoring frequency and observation cycle are long, which easily leads to delayed intervention when the condition deteriorates. The SI reflects a patient’s degree of shock by dynamically monitoring the ratio of HR to SBP, providing an important basis for clinical decision making[13,14]. The early warning scoring system further refines the severity of the patient's condition by comprehensively evaluating the patient's HR, SBP, respiratory rate, body temperature, consciousness status, and other indicators, making treatment measures more precise and personalized[15,16]. The dynamic calculation of the SI combined with the comprehensive score of the EWS system realizes early risk stratification, which can trigger the immediate response of the multidisciplinary team earlier, with an average consultation time controlled within 30 min. This significantly reduces the decision-making delay caused by the lag of single-parameter evaluation in the traditional model[17,18], effectively optimizing the emergency treatment process and improving treatment efficiency. This mechanism, which can shorten the emergency decision-making time by 20%-30%, thereby shortening the patient's emergency, triage, waiting, hemostasis, and hospital stay time, is consistent with the research report of N et al[19].
Concurrently, the research results show that after 48 h of emergency intervention, the SpO2 and PaO2 in the observation group were higher than those in the control group (P < 0.05), whereas after 7 days of emergency intervention, the levels of Hb, PAB, and Alb in the observation group were higher than those in the control group (P < 0.05). The authors believe that the combination of the SI and EWS system can, through scientific evaluation, lead to more active and effective treatment measures, such as quickly establishing intravenous channels, timely infusion of blood products, and using hemostatic drugs, to more effectively maintain the stability of the patient's vital signs and improve respiratory function[20,21]. In particular, it can lead to early identification of insufficient tissue perfusion, strengthening the dynamic evaluation of respiratory rate, optimizing the fluid resuscitation strategy, considering the lactate clearance rate and central venous pressure as goal-oriented fluid resuscitation, avoiding pulmonary edema caused by excessive infusion of crystalloid solution, and early detection and prevention of acute respiratory distress syndrome. This result is consistent with the conclusion of Yun et al[22] that the "dynamic monitoring of respiratory parameters can reduce the incidence of ARDS”. Hb is a key index for evaluating the oxygen-carrying capacity of red blood cells, while PAB and Alb reflect the body's nutritional status and liver synthesis function and are important indicators that reflect the body's nutritional status, immune function, and prognosis[23,24]. The increase in their levels indicated that the patient's nutritional status and immune function improved, and the prognosis was better. Treatment measures, such as transfusion strategy and nutritional support guided by the combination of SI and EWS system, can effectively improve the patient's Hb level, increase the content of PAB and Alb, correct hypoalbuminemia, and enhance the patient's body immunity and ability to resist infection[25,26], thereby further reducing the occurrence of complications. Cali et al[27] also pointed out that score-based individualized transfusion can reduce the rebleeding rate by 15%-20%.
In addition, the study results also showed that the incidence of complications such as rebleeding, abdominal effusion, infection, and multiple organ dysfunction in the observation group was 3.39%, which was lower than the 13.56% in the control group (P < 0.05), and the satisfaction with emergency intervention in the observation group was 94.92%, which was higher than that in the control group (83.05%) (P < 0.05). The authors believe that the combined application of the SI and EWS system can more accurately assess the patient's condition to adopt more refined, individualized, and targeted treatment measures, effectively preventing the occurrence of complications. For example, when the SI is ≥ 1.0, interventional hemostasis is prioritized, which is conducive to the control of re-bleeding risk, which is consistent with the research results of Park et al[28] and others, who reported that interventional hemostasis can reduce the re-bleeding risk to < 5%. Dynamic monitoring of body temperature and consciousness in the EWS, timely application of antibiotics, and adjust
It is notable that although the combined application of the SI and EWS system achieved remarkable results in the emergency treatment of patients with primary liver cancer rupture, hemorrhage, and shock in this study, it still has certain limitations. For example, although the SI and EWS system can more comprehensively assess a patient's condition, they rely on the professional judgment and operational accuracy of medical staff and need to be combined with the patient's specific medical history, signs, laboratory test results, and other monitoring methods for comprehensive judgment, which may influence the treatment effect. In practical applications, the training of medical staff should be strengthened to improve their professional quality and operational skills and ensure the accuracy and reliability of the assessment results. In addition, the sample size of this study was limited, and future studies need to further expand the sample size and conduct multicenter, prospective studies to verify the universal applicability and effectiveness of the combined application of the SI and EWS system in the emergency treatment of patients with primary liver cancer rupture-induced hemorrhage and shock.
The combined SI and EWS system in patients with primary liver cancer rupture, hemorrhage, and shock can significantly shorten emergency treatment time, improve respiratory function and serological indicators, reduce the incidence of complications, and enhance patient satisfaction with emergency intervention, with higher clinical treatment efficiency and quality, making it worthy of promotion and application.
| 1. | Miyata T, Sugi K, Horino T, Ono A, Tagayasu Y, Nomoto D, Inoue M, Mizumoto T, Kubota T, Yanagida E, Murayama T, Miyanari N, Baba H. Conversion Surgery After Atezolizumab Plus Bevacizumab for Primary and Peritoneal Metastasis After Hepatocellular Carcinoma Rupture. Anticancer Res. 2023;43:943-947. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 9] [Reference Citation Analysis (0)] |
| 2. | Haider A, Siddiqa A, Mehmood M, Adrish M. Ramucirumab-Induced Hepatocellular Carcinoma Rupture and Gastrointestinal Perforation. Am J Case Rep. 2021;22:e929493. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 1] [Reference Citation Analysis (0)] |
| 3. | Yuksen C, Angkoontassaneeyarat C, Thananupappaisal S, Laksanamapune T, Phontabtim M, Namsanor P. Accuracy of Trauma on Scene Triage Screening Tool (Shock Index, Reverse Shock Index Glasgow Coma Scale and National Early Warning Score) to Predict the Severity of Emergency Department Triage: A Retrospective Cross-Sectional Study. Open Access Emerg Med. 2023;15:79-91. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 2] [Reference Citation Analysis (0)] |
| 4. | Holland M, Kellett J, Boulitsakis-Logothetis S, Watson M, Al Moubayed N, Green D. The variable relationship between the National Early Warning Score on admission to hospital, the primary discharge diagnosis, and in-hospital mortality. Intern Emerg Med. 2025;20:681-690. [RCA] [PubMed] [DOI] [Full Text] [Reference Citation Analysis (0)] |
| 5. | Radosavaljevic I, Miwa T, Kawade M, Unome S, Imai K, Takai K, Yamaji F, Fukuta T, Nomura S, Shimizu M. A case of non-occlusive mesenteric ischemia following hepatocellular carcinoma rupture. Clin J Gastroenterol. 2025;18:119-124. [RCA] [PubMed] [DOI] [Full Text] [Reference Citation Analysis (0)] |
| 6. | International EM. Retracted: Short-Term and Long-Term Curative Effect of Partial Hepatectomy on Ruptured Hemorrhage of Primary Liver Cancer after TAE. Emerg Med Int. 2024;2024:9892616. [RCA] [PubMed] [DOI] [Full Text] [Reference Citation Analysis (0)] |
| 7. | Akdur G, Daş M, Bardakci O, Akman C, Sıddıkoğlu D, Akdur O, Akçalı A, Erbaş M, Reşorlu M, Beyazit Y. Prediction of mortality in COVID-19 through combing CT severity score with NEWS, qSOFA, or peripheral perfusion index. Am J Emerg Med. 2021;50:546-552. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 5] [Cited by in RCA: 17] [Article Influence: 4.3] [Reference Citation Analysis (0)] |
| 8. | Kim AY, Wi DH, Lee JH, Kim KH, Park JH, Kim YJ, Song KJ, Shin SD, Ro YS. Prehospital National Early Warning Score as a predictor of massive transfusion in adult trauma patients. Am J Emerg Med. 2023;73:125-130. [RCA] [PubMed] [DOI] [Full Text] [Reference Citation Analysis (0)] |
| 9. | Cheng K, Cai N, Zhu J, Yang X, Liang H, Zhang W. Tumor-associated macrophages in liver cancer: From mechanisms to therapy. Cancer Commun (Lond). 2022;42:1112-1140. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1] [Cited by in RCA: 236] [Article Influence: 78.7] [Reference Citation Analysis (0)] |
| 10. | Essobiyou TB, Sambiani DM, Amavi AK, Tchangai B. Haemorrhagic rupture of hepatocellular carcinoma: Management of a case in a resource-constrained hospital in TOGO. Int J Surg Case Rep. 2022;95:107199. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Reference Citation Analysis (0)] |
| 11. | Sato A, Imai Y, Uchiya H, Uchida Y, Nakazawa M, Sugawara K, Nakayama N, Mochida S. Two Cases of Intraabdominal Bleeding Caused by Hepatocellular Carcinoma Rupture Soon after the Initiation of Chemotherapy with Lenvatinib. Intern Med. 2022;61:2301-2305. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 1] [Cited by in RCA: 1] [Article Influence: 0.3] [Reference Citation Analysis (0)] |
| 12. | Okamoto S, Matsui Y, Komoto S, Hiraki T. Transarterial Embolization for Cystic Artery Pseudoaneurysm Caused by Hepatocellular Carcinoma Rupture in the Gallbladder: A Case Report. Cureus. 2024;16:e56400. [RCA] [PubMed] [DOI] [Full Text] [Reference Citation Analysis (0)] |
| 13. | Kurimoto M, Yamanaka K, Hirata M, Umeda M, Yamashita T, Aoki H, Hanabata Y, Shinkura A, Tamura J. Emergency open drainage of massive hemoperitoneum and early stage left hepatectomy for abdominal compartment syndrome due to hepatocellular carcinoma rupture: a case report. Surg Case Rep. 2022;8:122. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Reference Citation Analysis (0)] |
| 14. | Wu ZQ, Wang F, Wang FP, Cai HJ, Chen S, Yang JY, Guo WB. Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in patients with hepatocellular carcinoma and portal vein tumor thrombus. World J Gastrointest Surg. 2024;16:2778-2786. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Reference Citation Analysis (0)] |
| 15. | Tang RSY, Kyaw MH, Teoh AYB, Lui RNS, Tse YK, Lam TYT, Chan SL, Wong VWS, Wu JCY, Lau JYW, Sung JJY. Endoscopic ultrasound-guided cyanoacrylate injection to prevent rebleeding in hepatocellular carcinoma patients with variceal hemorrhage. J Gastroenterol Hepatol. 2020;35:2192-2201. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 4] [Cited by in RCA: 4] [Article Influence: 0.8] [Reference Citation Analysis (0)] |
| 16. | Villavicencio Kim J, Elkhattib I, Guerrero Vinsard D. Balloon Retrograde Transvenous Obliteration for Treatment of Persistent Gastric Variceal Bleed in Patient With Hepatocellular Carcinoma. Cureus. 2020;12:e8796. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Reference Citation Analysis (0)] |
| 17. | Roussel E, Bubenheim M, Le Treut YP, Laurent A, Herrero A, Muscari F, Mabrut JY, Savier E, Boleslawski E, Ayav A, Lermite E, Doussot A, Regimbeau JM, Riboud R, Cherqui D, Schwarz L; FRENCH Network. Peritoneal Carcinomatosis Risk and Long-Term Survival Following Hepatectomy for Spontaneous Hepatocellular Carcinoma Rupture: Results of a Multicenter French Study (FRENCH-AFC). Ann Surg Oncol. 2020;27:3383-3392. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 9] [Cited by in RCA: 24] [Article Influence: 4.8] [Reference Citation Analysis (0)] |
| 18. | Tartaglia N, Di Lascia A, Cianci P, Fersini A, Pacilli M, Pavone G, Ambrosi A. Hemoperitoneum caused by spontaneous rupture of hepatocellular carcinoma in noncirrhotic liver. A case report and systematic review. Open Med (Wars). 2020;15:739-744. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 12] [Cited by in RCA: 13] [Article Influence: 2.6] [Reference Citation Analysis (0)] |
| 19. | N R, Narayanaswamy S, Hegde S. Clinical Study of a New Modified Early Warning Scoring System for Rapidly Evaluating Shock in Adults. Cureus. 2023;15:e38224. [RCA] [PubMed] [DOI] [Full Text] [Reference Citation Analysis (0)] |
| 20. | Ishihara K. A Case of Multiple Intratumoral Hemorrhage and Rupture of Hepatocellular Carcinoma after Starting Lenvatinib. Case Reports Hepatol. 2020;2020:6659388. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 2] [Cited by in RCA: 2] [Article Influence: 0.5] [Reference Citation Analysis (0)] |
| 21. | Almutary A, Althunayyan S, Alenazi K, Alqahtani A, Alotaibi B, Ahmed M, Osman IS, Kakpuri A, Alanazi A, Arafat M, Al-Mutairi A, Bashraheel F, Almazroua F. National Early Warning Score (NEWS) as Prognostic Triage Tool for Septic Patients. Infect Drug Resist. 2020;13:3843-3851. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 7] [Cited by in RCA: 22] [Article Influence: 4.4] [Reference Citation Analysis (0)] |
| 22. | Yun H, Park JH, Choi DH, Shin SD, Jang MJ, Kong HJ, Kim SW. Enhancement in Performance of Septic Shock Prediction Using National Early Warning Score, Initial Triage Information, and Machine Learning Analysis. J Emerg Med. 2021;61:1-11. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 2] [Cited by in RCA: 6] [Article Influence: 1.5] [Reference Citation Analysis (0)] |
| 23. | Swersky A, Mohan P. Embolization of hemorrhage from a ruptured hepatocellular carcinoma via the false lumen of an aortic dissection using transradial access. J Card Surg. 2020;35:2375-2378. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1] [Cited by in RCA: 1] [Article Influence: 0.2] [Reference Citation Analysis (0)] |
| 24. | Lee YR, Park SY, Tak WY. Treatment Outcomes and Prognostic Factors of Acute Variceal Bleeding in Patients with Hepatocellular Carcinoma. Gut Liver. 2020;14:500-508. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 8] [Cited by in RCA: 25] [Article Influence: 5.0] [Reference Citation Analysis (0)] |
| 25. | Kohya R, Sugiura R, Yamamoto Y, Naruse H, Hatanaka K, Kinoshita K, Abiko S, Miyamoto S, Suzuki K, Kushibiki H, Munakata S, Shimoyama N. Hepatocellular Carcinoma Rupture after Introducing Lenvatinib: An Autopsy Case Report. Intern Med. 2023;62:995-998. [RCA] [PubMed] [DOI] [Full Text] [Reference Citation Analysis (0)] |
| 26. | Zhang X, Tsauo J, Tie J, Xue H, Zhao JB, Li JJ, Fang ZT, Guo WH, Li X. Emergent Transjugular Intrahepatic Portosystemic Shunt Creation for Acute Gastric Variceal Bleeding in Patients with Hepatocellular Carcinoma. J Vasc Interv Radiol. 2022;33:702-706. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 3] [Reference Citation Analysis (0)] |
| 27. | Cali J, Chevallier O, Guillen K, Latournerie M, Mazit A, Aho-Glélé LS, Loffroy R. Selective Arterial Embolization of Ruptured Hepatocellular Carcinoma with N-Butyl Cyanoacrylate and Lipiodol: Safety, Efficacy, and Short-Term Outcomes. J Pers Med. 2023;13:1581. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 1] [Reference Citation Analysis (0)] |
| 28. | Park J, Jeong YS, Suh YS, Kim HC, Chung JW, Choi JW. Clinical course and role of embolization in patients with spontaneous rupture of hepatocellular carcinoma. Front Oncol. 2022;12:999557. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 4] [Reference Citation Analysis (0)] |
| 29. | Qiu Y, Wang T, Yang X, Shen S, Yang Y, Wang W. Development and Validation of Artificial Neural Networks for Survival Prediction Model for Patients with Spontaneous Hepatocellular Carcinoma Rupture After Transcatheter Arterial Embolization. Cancer Manag Res. 2021;13:7463-7477. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 2] [Cited by in RCA: 6] [Article Influence: 1.5] [Reference Citation Analysis (0)] |
| 30. | Liengswangwong W, Siriwannabhorn R, Leela-Amornsin S, Yuksen C, Sanguanwit P, Duangsri C, Kusonkhum N, Saelim P. Comparison of Modified Early Warning Score (MEWS), Simplified Acute Physiology Score II (SAPS II), Sequential Organ Failure Assessment (SOFA), and Acute Physiology and Chronic Health Evaluation II (APACHE II) for early prediction of septic shock in diabetic patients in Emergency Departments. BMC Emerg Med. 2024;24:161. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 1] [Reference Citation Analysis (0)] |
